Tripura Malaria death roll rises to 41
India | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2013
Singapore: "At least 41 people, including 31 children, have died and more than 22,000 have fallen ill since the first we...Read more
Dr. Reddy's, Merck Serono enter partnership
India | News | By BioSpectrum Bureau | 0 Comment | 07 Jun, 2012
Singapore: Dr. Reddy's Laboratories and Merck Serono, a division of Merck KGaA, Darmstadt, Germany, have entered into a ...Read more
Biological E to supply vaccine to Vacsera of Egypt
India | News | By BioSpectrum Bureau | 0 Comment | 01 Jul, 2013
Singapore: Biological E has entered into a long term supply agreement with Vacsera (and its subsidiary Egyvac), an Egypt...Read more
Now Ranbaxy's Mohali unit under FDA scanner
India | News | By BioSpectrum Bureau | 0 Comment | 24 Jun, 2013
Singapore: Merely a month after Indian drug major, Ranbaxy, pleaded guilty of having misled the USFDA investigations, se...Read more
India ranks 2nd in terms of total company revenues
India | Analysis | By BioSpectrum Bureau | 0 Comment | 18 Jun, 2013
India emerged as the second largest country in terms of the total revenue generated by companies during the calendar yea...Read more
Cold tolerant gene identified in trout fish
India | News | By BioSpectrum Bureau | 0 Comment | 31 Oct, 2012
New Delhi: A group of scientists at the directorate of Cold Water Fisheries Research, Bhimtal, led by Dr Ashoktaru Barat...Read more
Bilcare to implement drug authentication project
India | News | By BioSpectrum Bureau | 0 Comment | 31 May, 2012
Mumbai: The Council of Scientific and Industrial Research (CSIR), India, under its New Millennium Indian Technology Lead...Read more
DNDi, Cipla to work on ARV therapy for children
India | News | By BioSpectrum Bureau | 0 Comment | 23 Jul, 2012
Mumbai: The Drugs for Neglected Diseases initiative (DNDi), a not-for-profit research and development (R&D) organiza...Read more
FDA continues review of Crofelemer beyond goal date
India | Regulatory | By BioSpectrum Bureau | 0 Comment | 06 Sep, 2012
Mumbai: The Food and Drug Administration has advised Salix Pharmaceuticals, Mumbai-based Glenmark's collaborative partne...Read more
Biocon clocks revenue worth $121 mn
India | News | By BioSpectrum Bureau | 0 Comment | 30 Jul, 2013
Bangalore: Indian biopharma giant Biocon reported healthy growth of 22 percent for Q1 FY14. The firm clocked revenues wo...Read more
Trivitron JV to lead immunodiagnostics sector in 3 years
India | News | By BioSpectrum Bureau | 0 Comment | 08 Nov, 2012
Bangalore: Trivitron Healthcare entered in a strategic partnership with Diasorin Group, a global leader in $11 billion ...Read more
Sandoz focuses on developing modern drugs for TB'
India | News | By BioSpectrum Bureau | 0 Comment | 22 Mar, 2012
Sandoz is the generic drug subsidiary of Novartis, a multinational pharmaceutical company. The company develops, manufac...Read more
What the UK plans to do at Bangalore India BIO?
India | News | By BioSpectrum Bureau | 0 Comment | 30 Jan, 2014
A positive business environment, access to global expertise and the presence of world renowned universities, is helping ...Read more
Accuray announces first two CyberKnife systems in India
India | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2013
Singapore: Accuray, the premier radiation oncology company, announced that Medanta - The Medicity Cancer Institute, and...Read more
India's new pharma pricing policy will be a profitability challenge: Glenn Saldanha
India | Opinion | By BioSpectrum Bureau | 0 Comment | 20 May, 2013
The Indian pharmaceutical industry has witnessed a healthy growth in the last decade, driven by factors like rising cons...Read more
Asia's challenge: Meeting US, EU requirements
India | Opinion | By BioSpectrum Bureau | 2 Comment | 12 Oct, 2012
One of the biggest challenges in developing and manufacturing antibodies is proving the equivalence or similarity to the...Read more
Cipla acquires 51 percent stake in Yemen
India | News | By BioSpectrum Bureau | 0 Comment | 05 Jul, 2014
Singapore: Given the recent preference to local manufacturing, this secures the company's presence in a fast growing mar...Read more
Asia has potential in NGS research: Dr Partha Majumdar
India | Influencers | By BioSpectrum Bureau | 0 Comment | 02 Aug, 2012
Dr Partha Majumder is a principal investigator representing India in the International Cancer Genome Consortium, focussi...Read more